Steve Damment
Fondateur chez Aluztura Bio Ltd.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Stephen Stamp | M | 62 | 5 ans | |
James Ford | M | - | 29 ans | |
David Redfern | M | 57 | 30 ans | |
Dmitry Zamoryakhin | M | 44 | 3 ans | |
Graham Rivers | M | - | 26 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Nicholas Robbins-Cherry | M | 54 | - | |
Craig Cook | M | 57 | - | |
James Phillips | M | 61 | 5 ans | |
Michele Luzi | M | 66 | 9 ans | |
John Johnston | M | 65 | 5 ans | |
Christopher Viehbacher | M | 64 | 20 ans | |
Richard Sykes | M | 79 | 7 ans | |
Alex Howarth | M | 55 | 10 ans | |
Michèle Barzach | M | - | 7 ans | |
Pavlo Protopapa | M | 57 | - | |
Jeff Jonas | M | 71 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 5 ans |
William Louv | M | - | 21 ans | |
Tatjana Anni Hilde May | F | 58 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 7 ans |
Robert Carr | M | - | 26 ans | |
Julian Heslop | M | 70 | 13 ans | |
Gregg Brandyberry | M | - | 16 ans | |
John Lepore | M | - | 15 ans | |
Christopher Tovey | M | 59 | 19 ans | |
Roger Connor | M | - | 24 ans | |
Jay C. Strum | M | - | 14 ans | |
Thierry Loriot | M | - | - | |
Sjoerd Wadman | M | - | 12 ans | |
Robin M. Young | M | 57 | 7 ans | |
Frédéric Duchesne | M | 64 | 1 ans | |
Lawson Macartney | M | 66 | 12 ans | |
Anne Brindley | M | 59 | 3 ans | |
David M. Pernock | M | 69 | 16 ans | |
James Wu | M | - | 10 ans | |
Charlie Sanders | M | 91 | 5 ans | |
Michael Allen Luther | M | 67 | 15 ans | |
David Rowe | M | 57 | 20 ans | |
Graham Ross | M | 64 | 11 ans | |
Song Gao | M | 52 | 22 ans | |
Monica Viziano | M | 57 | 6 ans | |
Sam Barker | M | - | 1 ans | |
Hu Li | M | 59 | 19 ans | |
Ian Pitfield | M | 58 | 23 ans | |
Lisa Trivison Beck | F | 62 | 24 ans | |
Clare Khan | M | 72 | 11 ans | |
Melissa Beelen | F | - | 12 ans | |
Myra Rosario Herrle | M | - | 9 ans | |
Lisa Bright | F | 56 | 17 ans | |
Edgar Cale | M | 60 | 21 ans | |
Kimberly Park | F | 60 | 12 ans | |
Daniel G. Marquess | M | 55 | 4 ans | |
Mark A. Smith | M | 68 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 1 ans |
Vivid Sehgal | M | 56 | 6 ans | |
Brian Blakey | M | 61 | 6 ans | |
Dean Hakanson | M | 72 | 7 ans | |
Nick Hirons | M | - | - | |
Carol Ashe | F | 66 | 13 ans | |
Peter John Murray | M | - | - | |
Lieven Nuyttens | M | 57 | 6 ans | |
Duncan Learmouth | M | - | - | |
Randall K. Johnson | M | 77 | 20 ans | |
Tamar Howson | F | 75 | 9 ans | |
James Andrews Grant | M | 86 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 6 ans |
Howard H. Pien | M | 66 | 12 ans | |
George Poste | M | 79 | 7 ans | |
Eric Carter | M | 72 | - | |
Joseph M. Spagnardi | M | 60 | 11 ans | |
Faheem Hasnain | M | 65 | 14 ans | |
Leslie Hudson | M | 76 | 6 ans | |
David John Kappler | M | 76 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 4 ans |
Matthew Emmens | M | 72 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 5 ans |
Maxine Gowen | M | 66 | 10 ans | |
Robert Ruffolo | M | 74 | 16 ans | |
Anita Graham | F | 52 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 4 ans |
Tim Tyson | M | 71 | 6 ans | |
Dean Mitchell | M | 68 | 15 ans | |
Roger L. Hawley | M | 71 | 14 ans | |
Joseph Schachle | M | 59 | 3 ans | |
Patrick J. Langlois | M | 78 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 3 ans |
Paul Magrez | M | - | 4 ans | |
Neil Pegg | M | - | - | |
David Lawrence | M | 61 | 13 ans | |
David Laskow-Pooley | M | 69 | 8 ans | |
Paul Carter | M | 63 | 10 ans | |
Robert G. Pietrusko | M | 76 | 1 ans | |
Marc Rubin | M | 69 | 13 ans | |
Christopher J. Morl | M | 65 | 3 ans | |
Dimitri Dimitriou | M | - | 5 ans | |
Douglas B. Snyder | M | 60 | 6 ans | |
Kathleen Anne Nealon | F | 70 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 4 ans |
Adrian Rawcliffe | M | 52 | 17 ans | |
Argeris Karabelas | M | 71 | 6 ans | |
Lisa Porter | M | 60 | 5 ans | |
Barbara H. Deptula | F | 69 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 4 ans |
Eliseo Salinas | M | 69 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 4 ans |
Michael V. Milburn | M | - | 10 ans | |
Elaine Jones | M | 69 | - | |
Huai Zheng Peng | M | 62 | 1 ans | |
Leon Palandjian | M | 54 | 3 ans | |
Michael Cola | M | 64 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 5 ans |
Wissam Al-Adani | M | 50 | 6 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Royaume-Uni | 100 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Steve Damment
- Réseau Personnel